Luteolytic potency of a prostaglandin analogue at different stages of the oestrous cycle in red deer (Cervus elaphus) hinds.

The luteolytic effect of the prostaglandin F2 alpha analogue, cloprostenol, was investigated in red deer by monitoring concentrations of plasma progesterone, the induction of oestrus and ovulation, and fertility. Oestrus was synchronized in 48 adult hinds by intravaginal delivery of exogenous progesterone for 12 days and i.m. injection of 250 iu pregnant mares' serum gonadotrophin at progesterone withdrawal. A single i.m. dose of 500 micrograms cloprostenol was administered at day 4, 6, 8, 10, 12, 14 or 16 of the subsequent oestrous cycle (n = 6 hinds per treatment; day 0 = oestrus). Six other hinds were monitored by intensive collection of blood samples between day 16 and day 19 to define changes in plasma progesterone concentrations during spontaneous luteolysis. Samples of jugular blood, collected every second day throughout the study and every 6 h for 78 h from the time of administration of cloprostenol, were analysed for plasma concentrations of progesterone and LH. Oestrus was detected by continuous observation during the period of intensive collection of blood samples and all hinds were subjected to transrectal ultrasonography to assess pregnancy status. On the basis of changes in plasma progesterone concentrations, cloprostenol induced complete luteolysis in all hinds treated on days 8-16 and in five of six hinds treated on day 6. Oestrus, ovulation and conception occurred in 25 (69%), 28 (78%) and 25 (69%), respectively, of hinds treated on days 6-16 inclusive (n = 36). Luteolysis was incomplete in all hinds treated on day 4, and none of the animals exhibited oestrus or ovulated; luteolysis was incomplete for one hind treated on day 6.(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of exogenous gonadotrophins on oestrus, the LH surge and the timing and rate of ovulation in red deer (Cervus elaphus).

Red deer hinds (n = 38) were treated in the breeding season with five different gonadotrophin regimens to investigate the temporal relationship between oestrus, ovulation and the LH surge. All hinds were treated with progesterone-impregnated controlled internal drug release (CIDR) devices to synchronize oestrus. The five treatments were as follows: treatment 1, controls; treatments 2, 3 and 4, 1200 iu pregnant mares' serum gonadotrophin (PMSG) was administered i.m. 72 h before CIDR device withdrawal (treatments 3 an 4 were also injected i.v. with 0.4 mg synthetic GnRH 12 or 18 h after CIDR device withdrawal, respectively); treatment 5, 200 iu PMSG was administered i.m. 72 h before CIDR device withdrawal and 0.5 iu FSH was administered in eight equal doses at intervals of 12 h starting from the time of PMSG injection. The hinds were run with crayon-harnessed stages to determine the time of oestrus onset. Blood samples were collected every 2 days for 26 days after CIDR device removal to determine concentrations of plasma progesterone and every 2 h for 72 h after CIDR device removal to determine plasma LH profiles. Laparoscopy for ovary examination was performed 6 or 12 h after oestrus onset and was repeated twice at intervals of 12 h. Final ovulation rate was determined on day 7 after CIDR device removal. All hinds received 500 micrograms cloprostenol i.m. on day 13. A total of 30 and 34 hinds exhibited oestrus and ovulation, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of exogenous melatonin on prolactin secretion, lactogenesis and reproductive seasonality of adult female red deer (Cervus elaphus).

The effects of administration of exogenous melatonin to pregnant red deer hinds on prolactin secretion, lactogenesis and reproductive seasonality were studied. Mature hinds (n = 23) were allocated to one of four treatments. Hinds in treatment 1 (n = 6) each received two subcutaneous melatonin implants (Regulin) at monthly intervals starting on 2 October, about 80 days before expected parturition. Hinds in treatment 2 (n = 6) received similar treatment starting on 2 November, about 40 days before calving, whereas hinds in treatment 3 (n = 5) received treatment starting on the actual day of calving (about 10 December). Final implants were delivered on 1 February, with overall treatment durations of 150, 120 and 90 days for treatments 1-3, respectively. Hinds in treatment 4 (n = 6) served as controls and received no melatonin treatment. Blood samples were taken twice a week from September to May, and plasma was analysed for progesterone and prolactin. Mammary development was assessed by palpation score (0-5) twice a week from October to April inclusive, and liveweights were recorded at least every two weeks throughout the trial. Calving occurred between 28 November and 24 December, with no significant differences among treatments (P > 0.10). Hinds in treatment 1 exhibited significant retardation of mammary gland development and liveweight gain leading up to parturition (P < 0.01). Furthermore, sex-adjusted calf birth weights were on average 3 kg lighter for treatment 1 (P < 0.05), with all calves either removed for bottle-rearing or having died within a few hours of birth.(ABSTRACT TRUNCATED AT 250 WORDS)

Endocrine responses and conception rates in fallow deer (Dama dama) following oestrous synchronization and cervical insemination with fresh or frozen-thawed spermatozoa.

In Expt 1, 59 mature fallow deer does were allocated to six treatments (n = 9-10 per treatment). Does assigned to treatments 1, 2 and 3 each received an i.m. injection of 500 micrograms cloprostenol on day 13 of a luteal cycle. Does in treatments 2 and 3 received 50 or 100 iu pregnant mares' serum gonadotrophin (PMSG), respectively, at the time of prostaglandin administration. Does assigned to treatments 4, 5 and 6 each received single intravaginal controlled internal drug release (CIDR) devices for 14 days. Does in treatments 5 and 6 received 50 or 100 iu PMSG, respectively, at the time of CIDR device withdrawal. Incidence of oestrus was higher following treatment with CIDR devices than with prostaglandin (29 of 30 versus 12 of 29, P < 0.001). PMSG induced earlier onset of oestrus (34.6 +/- 0.9 h versus 44.7 +/- 2.4 h, P < 0.01) and reduced the range in the time to onset of oestrus (from 22 to 8 h for prostaglandin-treated does and from 36 to 14 h for progesterone-treated does). The number of LH surges was higher following treatment with CIDR devices than with prostaglandin (10 of 12 versus 3 of 12, P < 0.01). The overall mean peak LH concentration and time to LH peak were 30.2 +/- 3.4 ng ml-1 and 45.2 +/- 2.2 h after prostaglandin administration or CIDR device withdrawal. The overall median time of ovulation was 26 h after the onset of oestrus.(ABSTRACT TRUNCATED AT 250 WORDS)

Relationship between the onset of oestrus, the preovulatory surge in luteinizing hormone and ovulation following oestrous synchronization and superovulation of farmed red deer (Cervus elaphus).

The timing of ovulation relative to the onset of oestrus and the preovulatory surge in luteinizing hormone (LH) was studied in red deer following treatments to synchronize oestrus and induce either a monovulatory or superovulatory response. Mature hinds (n = 36) were allocated randomly to two mating groups (n = 16 + 20), with respective treatments staggered by 4 weeks during the 1990 rut (March-April). Each hind was treated with an intravaginal controlled internal drug releasing (CIDR)-type S device for 14 days. Treatments to induce a monovulatory response included CIDR device alone (treatment A; n = 4 + 8) and additional injection of 200 iu pregnant mares' serum gonadotrophin (PMSG) at device removal (treatment B; n = 4 + 4). Treatments to induce a superovulatory response included injections of 200 iu PMSG and 0.5 units ovine follicle-stimulating hormone (FSH) at about time of removal of CIDR devices (treatment C; n = 4 + 4) and further treatment with gonadotrophin-releasing hormone (GnRH) analogue 18 h after removal of CIDR devices (treatment D; n = 4 + 4). The hinds were run with crayon-harnessed stags from insertion of CIDR devices (12 March or 9 April) and blood samples were taken every second day to determine plasma progesterone. Further blood samples were collected for determination of plasma LH and progesterone via indwelling jugular cannulae every 2 h for 72 h from removal of CIDR devices. Hinds were allocated randomly to an initial ovarian examination by laparoscopy at either 16 or 20 h (A and B), or 12 or 16 h (C and D) after the onset of oestrus, with laparoscopy repeated at intervals of 8 h until either ovulation was recorded (A and B), or for four successive occasions (C and D). All hinds received cloprostenol injections 15 days after device removal. A total of 28 hinds (78%) exhibited oestrus and a preovulatory LH surge, with mean (+/- SEM) times to onset of oestrus of 44.6 +/- 1.0 h (A; n = 7), 37.4 +/- 2.0 h (B; n = 7), 16.3 +/- 1.7 h (C; n = 6) or 14.0 +/- 1.7 h (D; n = 8). Failure to exhibit oestrus or LH surge was most prevalent among hinds in treatment A early in the rut.(ABSTRACT TRUNCATED AT 400 WORDS)

Laparoscopic intra-uterine insemination of fallow deer with frozen-thawed or fresh semen after synchronisation with CIDR devices.

This study investigated the efficacy of fixed-time laparoscopic intra-uterine insemination of farmed fallow deer (Dama dama) with frozen-thawed or fresh semen. In the trials with frozen-thawed semen, a total of 547 mature non-lactating does across five New Zealand farms were used. For oestrous synchronisation and artificial insemination, a standard control regimen was applied to at least 30% of the does on each farm, involving the insertion of single CIDR type-G devices intravaginally for 14 days, deposition of 50 x 10(6) frozen-thawed spermatozoa at 65 hours after withdrawal of the CIDR device and the continuous presence of vasectomised bucks from the insertion of the CIDR device until 10 days after insemination. Various aspects of this protocol were changed for the remaining does on each farm, including inseminations at 60 or 70 hours, the absence of vasectomised bucks, insemination with 25 x 10(6) or 10 x 10(6) spermatozoa, synchronisation with CIDR type-S devices and synchronisation with prostaglandin. The conception rate, based on rectal ultrasonography at 45 days after insemination, was 67% across all treatments (n=547). Corrected conception rates (+/-s.e.), calculated following between-farm adjustments, were 67+/- 3% for the control regimen, 67+/- 9% and 73 +/- 8% for inseminations at 60 and 70 hours respectively, 61 +/- 9% for absence of bucks, 80 +/- 8% and 74 +/- 9% for inseminations with 25 x 10(6) and 10 x 10(6) spermatozoa respectively, 62 +/- 10% for CIDR type-S device synchronisation, and 49 +/- 10% for prostaglandin synchronisation. Despite apparent differences, none of the treatments resulted in adjusted conception rates that were significantly different from the control regimen (P>0.01). In the trials with fresh semen, 216 does in the USA were inseminated at 69-71 hours after withdrawal of the CIDR device using either cryopreserved semen from New Zealand (n=158; 25 x 10(6) spermatozoa per inseminate) or fresh semen (n=58; 7.5 x10(6) to 20 x 10(6) spermatozoa per inseminate) collected less than 10 hours earlier. The overall conception rates were 77% and 81% respectively, with no significant differences between semen type (frozen v. fresh) or fresh spermatozoa number per inseminate (P>0.01). A further 102 does in New Zealand similarly received fresh semen from 3/4 Mesopotamian buck. Doses of 10 x 10(6) (n=35), 5 x 10(6) (n=32) or 2.5 x 10(6) (n=35) spermatozoa per inseminate were delivered at 69-71 hours after withdrawal of the CIDR device. The conception rates were 77%, 66% and 51% respectively, reflecting a dose effect (P<0.05). However, 1/4 Mesopotamian does in the group (n=19) exhibited higher conception rates (95% overall) irrespective of semen dose, possibly indicating a semen/recipient genotype interaction. It is concluded that laparoscopic intra-uterine insemination of fallow deer with frozen-thawed or fresh semen at fixed intervals after removal of a CIDR device can give acceptable conception rates under a range of on-farm management options and semen doses.